Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of split tablet dosing versus alternate-day dosing of warfarin
TCTR20161212001Phase 4Completed
- Sponsor
- Siriraj Research Development Fund
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of warfarin in Atrial fibrillation (AFib), sponsored by Siriraj Research Development Fund. Started Jan 2018; status: completed.
02
Drugs
warfarin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on TCTR20161212001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20161212001.